Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 20135346)


Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.

Silvestri A, Palumbo F, Rasi I, Posca D, Pavlidou T, Paoluzi S, Castagnoli L, Cesareni G.

PLoS One. 2015 Aug 20;10(8):e0136250. doi: 10.1371/journal.pone.0136250. eCollection 2015.


The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.

Abdalla M, Sabbineni H, Prakash R, Ergul A, Fagan SC, Somanath PR.

Br J Pharmacol. 2015 Aug;172(16):4173-88. doi: 10.1111/bph.13203. Epub 2015 Jul 6.


Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.

Sesen J, Dahan P, Scotland SJ, Saland E, Dang VT, Lemarié A, Tyler BM, Brem H, Toulas C, Cohen-Jonathan Moyal E, Sarry JE, Skuli N.

PLoS One. 2015 Apr 13;10(4):e0123721. doi: 10.1371/journal.pone.0123721. eCollection 2015.


Impacts of metformin and aspirin on life history features and longevity of crickets: trade-offs versus cost-free life extension?

Hans H, Lone A, Aksenov V, Rollo CD.

Age (Dordr). 2015 Apr;37(2):31. doi: 10.1007/s11357-015-9769-x. Epub 2015 Apr 2.


Metformin and erlotinib synergize to inhibit basal breast cancer.

Lau YK, Du X, Rayannavar V, Hopkins B, Shaw J, Bessler E, Thomas T, Pires MM, Keniry M, Parsons RE, Cremers S, Szabolcs M, Maurer MA.

Oncotarget. 2014 Nov 15;5(21):10503-17.


Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities.

Li T, Wang G.

Int J Mol Sci. 2014 Oct 20;15(10):18856-91. doi: 10.3390/ijms151018856. Review.


The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.

Kim WG, Choi HJ, Kim TY, Shong YK, Kim WB.

Korean J Intern Med. 2014 Jul;29(4):474-81. doi: 10.3904/kjim.2014.29.4.474. Epub 2014 Jun 27.


Regulation of metformin response by breast cancer associated gene 2.

Buac D, Kona FR, Seth AK, Dou QP.

Neoplasia. 2013 Dec;15(12):1379-90.


Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.

Garofalo C, Capristo M, Manara MC, Mancarella C, Landuzzi L, Belfiore A, Lollini PL, Picci P, Scotlandi K.

PLoS One. 2013 Dec 31;8(12):e83832. doi: 10.1371/journal.pone.0083832. eCollection 2013.


Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice.

Kusne Y, Goldberg EL, Parker SS, Hapak SM, Maskaykina IY, Chew WM, Limesand KH, Brooks HL, Price TJ, Sanai N, Nikolich-Zugich J, Ghosh S.

Age (Dordr). 2014 Feb;36(1):199-212. doi: 10.1007/s11357-013-9572-5. Epub 2013 Aug 16.


Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).

Subbiah V, Brown RE, Jiang Y, Buryanek J, Hayes-Jordan A, Kurzrock R, Anderson PM.

PLoS One. 2013 Jul 29;8(7):e68985. doi: 10.1371/journal.pone.0068985. Print 2013.


Impact of targeting insulin-like growth factor signaling in head and neck cancers.

Limesand KH, Chibly AM, Fribley A.

Growth Horm IGF Res. 2013 Oct;23(5):135-40. doi: 10.1016/j.ghir.2013.06.001. Epub 2013 Jun 29. Review.


Cancer, physical activity, and exercise.

Brown JC, Winters-Stone K, Lee A, Schmitz KH.

Compr Physiol. 2012 Oct;2(4):2775-809. doi: 10.1002/cphy.c120005. Review.


Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.

Karnevi E, Said K, Andersson R, Rosendahl AH.

BMC Cancer. 2013 May 10;13:235. doi: 10.1186/1471-2407-13-235.


Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.

Storozhuk Y, Hopmans SN, Sanli T, Barron C, Tsiani E, Cutz JC, Pond G, Wright J, Singh G, Tsakiridis T.

Br J Cancer. 2013 May 28;108(10):2021-32. doi: 10.1038/bjc.2013.187. Epub 2013 Apr 30.


Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.

Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H.

PLoS One. 2013 Apr 19;8(4):e61537. doi: 10.1371/journal.pone.0061537. Print 2013.


mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.

Melemedjian OK, Khoutorsky A, Sorge RE, Yan J, Asiedu MN, Valdez A, Ghosh S, Dussor G, Mogil JS, Sonenberg N, Price TJ.

Pain. 2013 Jul;154(7):1080-91. doi: 10.1016/j.pain.2013.03.021. Epub 2013 Mar 15.


AMPK and Exercise: Glucose Uptake and Insulin Sensitivity.

O'Neill HM.

Diabetes Metab J. 2013 Feb;37(1):1-21. doi: 10.4093/dmj.2013.37.1.1. Epub 2013 Feb 15. Erratum in: Diabetes Metab J. 2013 Apr;37(2):155.


Reversing the Warburg effect as a treatment for glioblastoma.

Poteet E, Choudhury GR, Winters A, Li W, Ryou MG, Liu R, Tang L, Ghorpade A, Wen Y, Yuan F, Keir ST, Yan H, Bigner DD, Simpkins JW, Yang SH.

J Biol Chem. 2013 Mar 29;288(13):9153-64. doi: 10.1074/jbc.M112.440354. Epub 2013 Feb 13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk